![Danny Bar-Zohar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Danny Bar-Zohar currently works at Merck KGaA, as Chief Executive Officer-Healthcare from 2025 and SwanBio Therapeutics, Inc., as Director from 2020.
Dr. Bar-Zohar also formerly worked at Novartis Pharma AG, as Global Head-Clinical Development & Analytics from 2013 to 2020 and Syncona Partners LLP, as Partner.
Dr. Bar-Zohar received his doctorate degree from Sackler School of Medicine.
Aktuelle Nachrichten zu Danny Bar-Zohar
Aktive Positionen von Danny Bar-Zohar
| Unternehmen | Position | Beginn |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01.06.2025 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Direktor/Vorstandsmitglied | 20.11.2020 |
Ehemalige bekannte Positionen von Danny Bar-Zohar
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Syncona Partners LLP
 Syncona Partners LLP Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | - |
Ausbildung von Danny Bar-Zohar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | |
Sackler School of Medicine
 Sackler School of Medicine Functions as a College/University | |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. Operates as a clinical stage gene therapy company that develops treatments for neurological disorders |
